Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1350.00
-3.00 (-0.22%)
< Home < Back

Cipla - Quaterly Results

Date: 26-07-2024
The revenue for the June 2024 quarter is pegged at Rs. 45010.50 millions, about 14.77% up against Rs. 39219.00 millions recorded during the year-ago period.A comparatively good net profit growth of 32.18% to Rs. 10559.40 millions was reported for the quarter ended June 2024 compared to Rs. 7988.80 millions of previous same quarter.Operating profit for the quarter ended June 2024 rose to 15733.80 millions as compared to 12341.90 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 45010.50 39219.00 14.77 45010.50 39219.00 14.77 165743.40 143453.40 15.54
Other Income 2135.20 1579.80 35.16 2135.20 1579.80 35.16 10706.60 4567.90 134.39
PBIDT 15733.80 12341.90 27.48 15733.80 12341.90 27.48 55548.10 38096.80 45.81
Interest 50.70 3.10 1535.48 50.70 3.10 1535.48 202.50 222.70 -9.07
PBDT 15683.10 12338.80 27.10 15683.10 12338.80 27.10 55345.60 36015.10 53.67
Depreciation 1378.60 1359.50 1.40 1378.60 1359.50 1.40 5875.90 5959.10 -1.40
PBT 14304.50 10979.30 30.29 14304.50 10979.30 30.29 49469.70 30056.00 64.59
TAX 3745.10 2990.50 25.23 3745.10 2990.50 25.23 12327.80 8615.40 43.09
Deferred Tax 165.90 -89.50 -285.36 165.90 -89.50 -285.36 60.90 -400.90 -115.19
PAT 10559.40 7988.80 32.18 10559.40 7988.80 32.18 37141.90 21440.60 73.23
Equity 1615.00 1614.50 0.03 1615.00 1614.50 0.03 1614.70 1614.30 0.02
PBIDTM(%) 34.96 31.47 11.08 34.96 31.47 11.08 33.51 26.56 26.20